CD45RA+Regulatory T Cells (Tregs) in the Graft is Inversely Related to Donor Age and Impacts Early Alloreactivity and Survival in Younger Patients Undergoing Haploidentical PBSC Transplantation with Post-Transplantation Cyclophosphamide (PTCy)

被引：0
|
作者：
Jaiswal, Sarita [1 ]
Bhakuni, Prakash [1 ]
Bharadwaj, Priyanka [1 ]
Joy, Aby [1 ]
Chakrabarti, Aditi [2 ]
Zaman, Shamsuz [1 ]
Chakrabarti, Suparno [1 ,2 ]
机构：
[1] Dharamshila Narayana Hosp & Res Ctr, Blood & Marrow Transplantat & Hematol, New Delhi, India
[2] Manashi Chakrabarti Fdn, Kolkata, India
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2018年 / 24卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
87
引用
收藏
页码：S83 / S84
页数：2
相关论文
共 9 条
  • [1] Higher CD45RA+ Regulatory T Cells in the Graft Improves Outcome in Younger Patients Undergoing T Cell-Replete Haploidentical Transplantation: Where Donor Age Matters
    Jaiswal, Sarita Rani
    Bhakuni, Prakash
    Joy, Aby
    Murli, Nisha
    Rajoreya, Ashok
    Chakrabarti, Aditi
    Chakrabarti, Suparno
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (10) : 2025 - 2033
  • [2] Feasibility and Efficacy of CD45RA+Depleted Donor Lymphocytes Infusion After Haploidentical Transplantation With Post-Transplantation Cyclophosphamide in Patients With Hematological Malignancies
    Castagna, Luca
    Valli, Viviana
    Timofeeva, Inna
    Capizzuto, Rossana
    Bramanti, Stefania
    Mariotti, Jacopo
    De Philippis, Chiara
    Sarina, Barbara
    Mannina, Daniele
    Giordano, Laura
    De Paoli, Federica
    van Beek, Jasper J. P.
    Zaghi, Elisa
    Calvi, Michela
    Di Vito, Clara
    Mavilio, Domenico
    Crocchiolo, Roberto
    Lugli, Enrico
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (06): : 478.e1 - 478.e5
  • [3] Graft versus host disease (GVHD) prophylaxis using postransplant cyclophosphamide (PTCy) preserves T regulatory CD4+lymphocytes (Tregs) in unmanipulated haploidentical transplantation (Haplo-SCT) patients
    Perez-Corral, A. M.
    Pascual, C.
    Gayoso, J.
    Kwon, M.
    Champ, D.
    Balsalobre, P.
    Munoz, C.
    Bastos, M.
    Serrano, D.
    Anguita, J.
    Diez-Martin, J. L.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S243 - S244
  • [4] Feasibility of Modified CD45RA Negative Donor Lymphocytes Infusion after Haploidentical Stem Cell Transplantation (HAPLO-SCT) with Post-transplantation Cyclophosphamide (PT-Cy) in Patients with Hematological Malignancies
    Bramanti, Stefania
    Magri, Filippo
    De Paoli, Federica
    Van Beek, Jasper
    Barbara, Sarina
    Timofeeva, Inna Anatolievna
    Mariotti, Jacopo
    Capizzuto, Rossana
    Chiara, De Philippis
    Mavilio, Domenico
    Santoro, Armando
    Lugli, Enrico
    Castagna, Luca
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 684 - 685
  • [5] Haploidentical T Cell-Replete Transplantation with Post-Transplantation Cyclophosphamide for Patients in or above the Sixth Decade of Age Compared with Allogeneic Hematopoietic Stem Cell Transplantation from an Human Leukocyte Antigen-Matched Related or Unrelated Donor
    Blaise, Didier
    Fuerst, Sabine
    Crocchiolo, Roberto
    El-Cheikh, Jean
    Granata, Angela
    Harbi, Samia
    Bouabdallah, Reda
    Devillier, Raynier
    Bramanti, Stephania
    Lemarie, Claude
    Picard, Christophe
    Chabannon, Christian
    Weiller, Pierre-Jean
    Faucher, Catherine
    Mohty, Bilal
    Vey, Norbert
    Castagna, Luca
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (01) : 119 - 124
  • [6] CD56-enriched donor cell infusion after post-transplantation cyclophosphamide for haploidentical transplantation of advanced myeloid malignancies is associated with prompt reconstitution of mature natural killer cells and regulatory T cells with reduced incidence of acute graft versus host disease: A pilot study
    Jaiswal, Sarita Rani
    Zaman, Shamsur
    Nedunchezhian, Murugaiyan
    Chakrabarti, Aditi
    Bhakuni, Prakash
    Ahmed, Margoob
    Sharma, Kanika
    Rawat, Sheh
    O'Donnell, Paul
    Chakrabarti, Suparno
    CYTOTHERAPY, 2017, 19 (04) : 531 - 542
  • [7] Early and sequential CTLA4Ig primed donor lymphocyte infusions (DLI) following post-transplantation cyclophosphamide (PTCY)-based haploidentical PBSC transplantation for advanced hematological malignancies promote proliferation of mature natural killer (NK) cells with cytotoxic potential and markedly reduces relapse-risk without increase in GVHD
    Jaiswal, S. R.
    Zaman, S.
    Bhakuni, P.
    Bansal, S.
    Deb, S.
    Bhargava, S.
    Chakrbarti, S.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S154 - S154
  • [8] Direct Integration of Anti-CD19 Chimeric-Antigen-Receptor (CAR) T Cells Early after Post-Transplantation Cyclophosphamide (PTCy) in Murine MHC-Haploidentical Hematopoietic Cell Transplantation (HCT) Exerts Anti-Tumor Effects without Causing Graft-Versus-Host Disease (GVHD)
    Patterson, Michael T.
    Mendu, Suresh K.
    Eckhaus, Michael A.
    Fletcher, Rochelle E.
    Nunes, Natalia S.
    Ishii, Kazusa
    Qin, Haiying
    Fry, Terry J.
    Kanakry, Christopher G.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S170 - S171
  • [9] NK-cell alloreactivity based on KIR/ligand mismatch in the donor vs recipient direction provides better graft-versus-tumor effect in patients with active hematological malignancies undergoing allogeneic T-replete haploidentical transplantation followed by post-transplant cyclophosphamide
    Wanquet, A.
    Bramanti, S.
    Harbi, S.
    Furst, S.
    Legrand, F.
    Faucher, C.
    Granata, A.
    Weiller, P-J
    Picard, C.
    Calmels, B.
    Lemarie, C.
    Chabannon, C.
    Castagna, L.
    Blaise, D.
    Devillier, R.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S186 - S186
1